These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Influence of atenolol and bopindolol on circadian heart rate. Fitscha P; Meisner W; Tiso B J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S51-4. PubMed ID: 2439821 [TBL] [Abstract][Full Text] [Related]
9. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers. Nieminen MS; Rapola J; Pellinen TJ; Toivonen L Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879 [TBL] [Abstract][Full Text] [Related]
10. Withdrawal of the long-acting beta blocker bopindolol is not associated with beta-adrenoceptor supersensitivity. Bolli P; Amann FW; Müller FB; Meyer B; Burckhardt D; Bühler FR J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S64-9. PubMed ID: 2439824 [TBL] [Abstract][Full Text] [Related]
11. Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria. Hosohata Y; Hattori K; Shen Y; Okuyama M; Kaneko H; Ohnuki T; Suzuki J; Nagatomo T Pharmacology; 1998 Oct; 57(4):180-7. PubMed ID: 9730775 [TBL] [Abstract][Full Text] [Related]
12. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol. Rangno RE; Langlois S Br J Clin Pharmacol; 1982; 13(Suppl 2):345S-351S. PubMed ID: 6125187 [TBL] [Abstract][Full Text] [Related]
13. The antihypertensive effect of atenolol and bopindolol in the elderly. Viskoper RJ; Laszt A; Oren S; Hochberg Y; Villa Y; Drexler I; Bregman L; Mishal J Neth J Med; 1989 Oct; 35(3-4):185-91. PubMed ID: 2574832 [TBL] [Abstract][Full Text] [Related]
14. The offset of beta-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline. Doggrell SA; Henderson CJ J Auton Pharmacol; 1998 Oct; 18(5):263-9. PubMed ID: 9831226 [TBL] [Abstract][Full Text] [Related]
15. Dose-finding study with bopindolol in arterial hypertension. Willimann P; Peter R; Siegenthaler H J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814 [TBL] [Abstract][Full Text] [Related]
16. Abrupt withdrawal of pindolol or metoprolol after chronic therapy. Szécsi E; Kohlschütter S; Schiess W; Lang E Br J Clin Pharmacol; 1982; 13(Suppl 2):353S-357S. PubMed ID: 7104154 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity. Aellig WH Br J Clin Pharmacol; 1985 Jun; 19(6):775-81. PubMed ID: 2862891 [TBL] [Abstract][Full Text] [Related]
18. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732 [TBL] [Abstract][Full Text] [Related]
19. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol. Ishibashi T; Mitomi A; Tatebe S; Imai S Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836 [TBL] [Abstract][Full Text] [Related]
20. Haemodynamic effects of bopindolol and atenolol in coronary artery disease. A noninvasive study. Rapola JM; Pellinen TJ; Toivonen L; Nieminen MS Ann Med; 1990; 22(4):221-4. PubMed ID: 2248757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]